Product Images Potassium Chloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Potassium Chloride NDC 72888-075 by Advagen Pharma Ltd, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Potassium chloride extended-release tablets,USP 1500mg - NDC 72888-076-01 - 100s bottle label - potassium chloride er tabs usp 1500mg 100s bottle
Each tablet contains 1500 mg potassium chloride (equivalent to 20 mEq). The tablets should be stored at room temperature between 20°-25°C (68°-77°F), with limited excursions permitted to extended-release 15°-30°C (59°-86°F). Dispense in a USP tight container and do not accept if seal over the bottle opening is broken or missing. The package insert should be referred to for full prescribing information. This is an FDA-approved assay test sample. Advagen Pharma Limited distributes the 100 tablets, and they are manufactured by Rubicon Research Private Limited in Ambernath, India, with Mfg Lic No. : KD-682.*
Potassium chloride extended-release tablets,USP 1500mg - NDC 72888-076-05 - 500s bottle label - potassium chloride er tabs usp 1500mg 500s bottle
Potassium chloride extended-release tablets,USP 750mg - NDC 72888-075-00 - 1000s bottle label - potassium chloride er tabs usp 750mg 1000s bottle
Potassium chloride extended-release tablets,USP 750mg - NDC 72888-075-01 - 100s bottle label - potassium chloride er tabs usp 750mg 100s bottle
Each tablet contains 750 mg of potassium chloride. It is recommended to store the medication in a USP tight container at room temperature, between 20°C and 25°C (68°F and 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). The medication should not be accepted if the seal over the bottle opening is broken or missing. The package insert provides full prescribing information. The medication is FDA approved, and the assay test sample preparation differs from USP. The NDC number is 72888-075-01. It is an extended-release tablet intended for prescription only. The medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The overprinting area is 50 mm X 15 mm.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.